Clinton, NY, United States of America

Karol K Mikula

This inventor holds 1 USPTO granted patent. Top assignee: American Home Products Corporation. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karol K Mikula. Retrieved from https://idiyas.com/inventor/karol-k-mikula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karol K Mikula

Introduction

Karol K Mikula is an accomplished inventor based in Clinton, NY (US). He has made significant contributions to the field of transdermal drug delivery, showcasing his expertise through his innovative patent.

Latest Patents

Karol K Mikula holds a patent titled "Eugenol enhancement of transdermal drug delivery." This patent discloses compositions and methods for enhancing the transdermal delivery of physiologically active agents across mammalian skin or membranes. The invention comprises a percutaneous transfer enhancing amount of eugenol and a drug, which has the potential to improve the effectiveness of drug delivery systems.

Career Highlights

Karol K Mikula is associated with American Home Products Corporation, where he applies his knowledge and skills in the development of pharmaceutical products. His work has contributed to advancements in drug delivery technologies, making a positive impact on healthcare.

Collaborations

Throughout his career, Karol has collaborated with notable colleagues, including Thomas W Leonard and Marcia S Schlesinger. These partnerships have fostered innovation and have been instrumental in the development of new ideas and technologies.

Conclusion

Karol K Mikula's contributions to the field of transdermal drug delivery through his patent and work at American Home Products Corporation highlight his role as a significant inventor. His innovative approaches continue to influence the pharmaceutical industry and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…